Dr. Rubin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1968 Peachtree Rd NW
Bldg
Atlanta, GA 30309Phone+1 404-605-2905Fax+1 678-244-6608
Education & Training
- University of Pennsylvania Health SystemFellowship, Gastroenterology, 1990 - 1992
- Pennsylvania Hospital of the University of Pennsylvania Health SystemChief Residency, Internal Medicine, 1989 - 1990
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1986 - 1989
- Weill Cornell MedicineClass of 1986
Certifications & Licensure
- FL State Medical License 2020 - 2025
- GA State Medical License 1995 - 2025
- MA State Medical License 2011 - 2014
- PA State Medical License 1988 - 1996
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Fellow American Association for the Study Of Liver Diseases
- Fellow (AGAF) American Gastroenterological Association, 2006
- Most Compassionate Doctor American Registry
- Join now to see all
Clinical Trials
- Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
- Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1 Start of enrollment: 2016 Jul 13
- A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis Start of enrollment: 2016 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 62 citationsEmricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With PlaceboCatherine Frenette, Giuseppe Morelli, Mitchell L. Shiffman, R. Todd Frederick, Raymond A. Rubin
Clinical Gastroenterology and Hepatology. 2019-03-01 - 519 citationsEfficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infe...Paul Y. Kwo, Eric Lawitz, Jonathan McCone, Eugene R. Schiff, John M. Vierling
Lancet. 2010-08-28 - 216 citationsPeginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trialIra M. Jacobson, Robert S. Brown, B. Freilich, Nezam H. Afdhal, P. Kwo
Hepatology. 2007-10-01
Authored Content
- Effort to Overhaul Liver-Transplant Protocols Would Cost Georgians’ LivesNovember 2018
Press Mentions
- Will COVID-19 Vaccine Protect Transplant Recipients? New Study Looks for AnswersMay 7th, 2021
- Piedmont to Study Moderna COVID-19 Vaccine in Organ Transplant RecipientsApril 28th, 2021
- Piedmont Atlanta Hospital Is Lead Enrolling Site for National Transplant Clinical TrialMarch 6th, 2020
- Join now to see all
Professional Memberships
- Fellow
- American Association for the Study of Liver DiseasesFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: